Xeris Biopharma Holdings (XERS) EBT Growth (5y) (2025 - 2026)

Xeris Biopharma Holdings (XERS) EBT Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	43.15 Bn	39.49 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.58 Bn	22.78 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.50 Bn	683.80 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn
7	Neurocrine Biosciences	15.48 Bn	15.09 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-
10	Xeris Biopharma Holdings	1.50 Bn	1.38 Bn	79.59 Mn

Download Data